Veterinary Imaging Market Size Projected to Reach USD 4,306.6 Million by 2034: Future Market Insights, Inc.

'What Picture Will the Veterinary Imaging Market Capture?' FMI Unveils with Top Insights. In the United States, the veterinary imaging market is projected to witness a steady growth trajectory, boasting a Compound Annual Growth Rate (CAGR) of 5.4% from 2024 to 2034. This growth aims to advance diagnostic capabilities and elevate patient care standards. The rise in pet ownership and increased spending on pet healthcare in the United States has led to a surge in demand for veterinary services.

NEWARK, Del., May 9, 2024 /PRNewswire/ -- The veterinary imaging market has been gaining significant traction globally, with a projected value of USD 2,272.8 million in 2024 and an estimated value of USD 4,306.6 million by 2034, developing at a CAGR of 6.6%. The rising demand for animal healthcare services, growing pet ownership, and increasing awareness about the importance of animal health primarily drive this growth.

The market is also propelled by advancements in imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, which provide accurate and early diagnosis of animal diseases and injuries, leading to better treatment outcomes. However, the high cost of equipment and initial investments, financing constraints, and the requirement for skilled workers pose significant challenges to the sector's growth.

One of the most frequently used applications in veterinary imaging is orthopedics. Fractures, sprains, and ligament tears are some of the most common orthopedic conditions that require accurate and detailed imaging for diagnosis and treatment. With the rising prevalence of chronic diseases in animals, the demand for orthopedic imaging equipment is expected to increase further.

Get Exclusive Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

The market is also witnessing a shift towards cloud-based platforms for remote consultations and affordable imaging systems, which would further drive market growth in the coming years. In conclusion, the veterinary imaging market is expected to witness significant growth in the coming years, driven by an increase in pet ownership, rising demand for animal healthcare services, and advancements in imaging technologies. 

Key Takeaways from the Market Study 

• Market share of 57.7% for 2024 has reported mass growth as pet owners seek specialized care in the veterinary imaging industry.
• Veterinarians encounter orthopedic applications as the most common practice, with a share of 30.9% for 2024.
• The veterinary imaging market in Canada is set to experience an exponential increase with a 10% CAGR through 2034.
• The veterinary imaging market in Malaysia is projected to grow at a CAGR of 7.8% through 2034.
• The veterinary imaging market in Indonesia is anticipated to develop at a CAGR of 7.1% through 2034.
• The veterinary imaging market in the United Kingdom is predicted to rise at a 6.1% CAGR through 2034.
• The veterinary imaging market in the United States is estimated to rise at a 5.4% CAGR through 2034.

"The adoption of digital imaging technologies has revolutionized the industry. It allows for efficient sharing and analysis of images, integration of AI, and miniaturization of devices, thereby speeding up the diagnosis and treatment process," - Opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.

Competitive Landscape

Growth initiatives taken in advancing the technologies are fueling market sales. Prominent players are collaborating with local companies to expand their distribution channels. Many key veterinary imaging manufacturers are inclined to invest significantly in innovation, research, and development practices to uncover increased applications in the veterinary imaging market.

Buy this Exclusive Report: https://www.futuremarketinsights.com/checkout/12368 

Recent Developments: 

• Antech introduced AIS RapidRead and Nu.Q® Canine Cancer Test to revolutionize veterinary diagnostics in April 2024.
• SK Telecom partnered with Vetology Innovations to bring X Caliber, an AI-powered diagnostic service for pets, to the U.S. market in January 2024.
• iCRco, Inc.'s CLARIS V Cone Beam Computed Tomography (CBCT) imaging device at Santa Barbara Zoo provided precise 3D imaging for enhanced veterinary diagnostics and treatment in June 2023.

Leading Veterinary Imaging Brands

• Esaote
• IDEXX Laboratories, Inc.
• IMV Technologies group
• Carestream Health
• Hallmarq Veterinary Imaging Ltd.
• MinXray, Inc.
• Universal Medical Systems, Inc.
• Agfa- Gevaert N.V.
• Mindray Medical International Ltd.
• GE Healthcare
• Siemens AG

Key Segments of Market Report

By Product Type:

Based on product type, the sector is primarily divided into equipment, software, and reagents. Veterinary imaging equipment is further categorized as radiography (X-ray), ultrasound imaging, magnetic resonance imaging, computed tomography, video endoscopy imaging, and other systems.

Radiography systems are also further bifurcated into computed and film-based radiography. Ultrasound imaging systems are divided into 2D and 3D US imaging. Computed tomography systems are also parted into two single and multi-slice CT.

By Animal Type:

Small and large animals are two categorized sections of animal type in this industry.

By Application:

Veterinary imaging is applied for cardiology, orthopedics, neurology, oncology, and others.

By End User:

Clinics, hospitals, institutes, and research centers are top end users of veterinary imaging.

By Region:

A regional analysis has been carried out in key countries of North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe.

Request For Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-12368

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI's related ongoing Coverage on Healthcare Market Insights Domain:

The global optical imaging market is anticipated to witness steady growth over the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 4.7%. From its estimated value of US$ 1,465.4 million in 2024, the market is expected to reach US$ 2,319.6 million by 2034.

The Specific Imaging Solution Market is currently valued at US$ 380.8 million as of 2022, and is expected to expand at a CAGR of 6.5% with US$ 756.3 Million valuation by 2033. According to recent research by Future Market Insights, app-based solutions dominate the market, holding a share of approximately 57.7% in 2022.

The global molecular imaging market is poised to attain US$ 5,437.2 million in 2023, projecting a robust CAGR of 11.0% and reaching US$ 15,457.48 million by the end of the forecast period.

The global magnetic resonance imaging (MRI) market, valued at approximately US$ 7.9 billion at the close of 2021, is expected to grow at a CAGR of 5.2%, reaching a valuation of US$ 13.6 billion by 2032.

The global cell culture market is forecasted to experience a CAGR of 4.7%, escalating from US$ 27,911.3 million in 2024 to US$ 44,593.1 million by 2034.

In the field of cell and gene therapies, the global cell therapy growth factor market is anticipated to witness exponential growth, doubling in size from US$ 664.8 million in 2024 to US$ 1,370.2 million by 2034.

The cancer tissue diagnostic market exhibits an upward trajectory, with its value expected to rise from US$ 15,302.2 million in 2024 to US$ 23,516.2 million in 2034. The adoption of cancer tissue diagnostics is set to grow at a CAGR of 4.5% from 2024 to 2034.

The veterinary dermatology market is forecasted to reach a valuation of US$ 8.9 billion by 2024, and is projected to soar to US$ 22 billion by 2034, experiencing a promising CAGR of 9.4% during the period from 2024 to 2034.

The molecular diagnostic market is poised for substantial growth, with projections indicating a climb to US$ 60,347.40 million by 2034 from US$ 39,611.00 million in 2024. Following a comprehensive market assessment, a moderate compound annual growth rate (CAGR) of 4.30% is anticipated through 2034.

The breath analyzers market is poised for steady growth, with a projected CAGR of 4.9% from 2024 to 2034. By 2034, the market is expected to reach a valuation of US$ 1,154.3 million, reflecting significant expansion.

The healthcare business intelligence (BI) market is forecasted to flourish, with a projected CAGR of 8.10% by the end of 2024, reaching a valuation of US$ 8,657.90 million by the end of the forecast period.

The therapeutic drug monitoring market is set to witness substantial revenue generation, with sales projected to surge from US$ 1,203.9 million in 2024 to US$ 2,527.9 million by 2034, marking a CAGR of 7.7% during this period.

The in vitro diagnostics market is poised for steady growth, with a projected CAGR of 4.8% during the forecast period. It is anticipated to surpass a value of US$ 129.9 billion by 2033, up from US$ 81.3 billion in 2023.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg